Difference between revisions of "Excerpta Medica"
(→List of Fake Journals) |
(→Activities) |
||
| Line 5: | Line 5: | ||
==Activities== | ==Activities== | ||
===Publishing Fake Journals=== | ===Publishing Fake Journals=== | ||
| − | |||
As of August 2009 the company discloses its policy on Industry sponsorship: | As of August 2009 the company discloses its policy on Industry sponsorship: | ||
| Line 13: | Line 12: | ||
The policy distinguishes between 'authors' and 'contributors' in a way that disguises the role of PR agencies and other ghost writers in process of publication. | The policy distinguishes between 'authors' and 'contributors' in a way that disguises the role of PR agencies and other ghost writers in process of publication. | ||
| − | ===List of Fake Journals=== | + | |
| + | ====Removing case studies from its website==== | ||
| + | Between 2006 and 2008 Excerpta Medica hosted case study material on its website. In July 2006 the list of case studies included: | ||
| + | |||
| + | * How did Excerpta Medica extend the life cycle of a mature product in a crowded and evolving market? | ||
| + | * How did Excerpta Medica create an online solution to strengthen a client's relationship with the medical community? | ||
| + | * How did Excerpta Medica increase the awareness of an underdiagnosed, life-threatening condition and educate the medical community on the available treatment options? | ||
| + | * With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?<ref>Excerpta Medica [http://web.archive.org/web/20060710073317/www.excerptamedica.com/index.cfm?vID=FE9A903C-1422-16B3-787CA38ABA6C1C9C Case Studies], retrieved from the Internet Archive dated 10 July 2006 on 26 August 2009.</ref> | ||
| + | |||
| + | By 2009, with one exception, all of these case studies had been removed. The remaining case study titled 'With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?' was, however changed by removing the phrase 'company-sponsored journal' and replacing it with 'company-sponsored publication'. The website includes a foootnote acknowledging that 'In an earlier version of this case study, we stated that a “company-sponsored journal” was created when in fact this was a “company-sponsored publication”.'<ref>Excerpta Medica [http://www.excerptamedica.com/index.cfm?vID=3CA13C48-1422-16B3-783DC2916631BB46 Case Studies: With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?], accessed 26 August 2009</ref> | ||
| + | |||
| + | ====List of Fake Journals==== | ||
[[Australasian Journal of Bone & Joint Medicine]], [[Australasian Journal of General Practice]], the [[Australasian Journal of Neurology]], the [[Australasian Journal of Cardiology]], the [[Australasian Journal of Clinical Pharmacy]], the [[Australasian Journal of Cardiovascular Medicine]].<ref>Bob Grant [http://www.the-scientist.com/blog/display/55679/ Elsevier published 6 fake journals] 07 May 2009, The Scientist, accessed 26 August 2009</ref> | [[Australasian Journal of Bone & Joint Medicine]], [[Australasian Journal of General Practice]], the [[Australasian Journal of Neurology]], the [[Australasian Journal of Cardiology]], the [[Australasian Journal of Clinical Pharmacy]], the [[Australasian Journal of Cardiovascular Medicine]].<ref>Bob Grant [http://www.the-scientist.com/blog/display/55679/ Elsevier published 6 fake journals] 07 May 2009, The Scientist, accessed 26 August 2009</ref> | ||
| − | ===List of current journals (2009)=== | + | ====List of current journals (2009)==== |
* [[American Journal of Geriatric Pharmacotherapy]] | [[Clinical Therapeutics]] | [[Current Therapeutic Research]] | [[Gender Medicine]]<ref>Excerpta Medica [http://www.excerptamedica.com//index.cfm?vID=FE9B781C-1422-16B3-78CB5EF0EDCFA983 Publication Policy], accessed 26 August 2009</ref> | * [[American Journal of Geriatric Pharmacotherapy]] | [[Clinical Therapeutics]] | [[Current Therapeutic Research]] | [[Gender Medicine]]<ref>Excerpta Medica [http://www.excerptamedica.com//index.cfm?vID=FE9B781C-1422-16B3-78CB5EF0EDCFA983 Publication Policy], accessed 26 August 2009</ref> | ||
Revision as of 16:20, 25 August 2009
|
This article is part of the Pharma_Portal project of Spinwatch. |
Excerpta Medica is a 'strategic medical communications agency'. It 'partners' with its clients in the pharmaceutical and biotech industry to 'educate the global health care community'.[1] It is owned by Elsevier, part of Reed Elsevier.
Contents
History
Activities
Publishing Fake Journals
As of August 2009 the company discloses its policy on Industry sponsorship:
- Content for Excerpta Medica’s Industry-Sponsored Publications is developed under the direction of an outside expert (eg, editor-in-chief, guest editor). Consistent with the Uniform Requirements and other generally accepted publication practices, Excerpta Medica distinguishes between authors and contributors. Authors are responsible for each article’s final content and are uniquely authorized to approve an article prior to its release/publication. Contributors are those individuals who helped to create the article, but who did not meet the criteria for authorship. Contributors are acknowledged in a manner that is appropriate for the publication (eg, on a Web site; on a masthead; in an acknowledgements section). Contributors may include, but are not limited to: copy editors; freelance writers; production staff; etc. The identity of the sponsor(s) for these publications is disclosed.[2]
The policy distinguishes between 'authors' and 'contributors' in a way that disguises the role of PR agencies and other ghost writers in process of publication.
Removing case studies from its website
Between 2006 and 2008 Excerpta Medica hosted case study material on its website. In July 2006 the list of case studies included:
- How did Excerpta Medica extend the life cycle of a mature product in a crowded and evolving market?
- How did Excerpta Medica create an online solution to strengthen a client's relationship with the medical community?
- How did Excerpta Medica increase the awareness of an underdiagnosed, life-threatening condition and educate the medical community on the available treatment options?
- With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?[3]
By 2009, with one exception, all of these case studies had been removed. The remaining case study titled 'With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?' was, however changed by removing the phrase 'company-sponsored journal' and replacing it with 'company-sponsored publication'. The website includes a foootnote acknowledging that 'In an earlier version of this case study, we stated that a “company-sponsored journal” was created when in fact this was a “company-sponsored publication”.'[4]
List of Fake Journals
Australasian Journal of Bone & Joint Medicine, Australasian Journal of General Practice, the Australasian Journal of Neurology, the Australasian Journal of Cardiology, the Australasian Journal of Clinical Pharmacy, the Australasian Journal of Cardiovascular Medicine.[5]
List of current journals (2009)
- American Journal of Geriatric Pharmacotherapy | Clinical Therapeutics | Current Therapeutic Research | Gender Medicine[6]
People
Mark Flanick, Vice President, Marketing & Business Development (USA) m.flanick@elsevier.com | Edward Roos, Global Managing Director e.roos@elsevier.com | Kathleen Coughlan, Marketing Director, Excerpta Medica Interactive k.coughlan@elsevier.com
Management Team Members
| David Benson, Business Controller | Amanda Horsford, Managing Director, Excerpta Medica Interactive | Mark Flanick, Vice President, Marketing & Business Development (USA) | Suzanne Hayes, Vice President, Operations | Rosa Real MD, CMPP, Director, Global Medical Communications | Brian O'Connor, US Managing Director | Erika Qualben, Manager Human Resources | Edward Roos, Global Managing Director | Jo-Ann West MSc, Publisher, Rapid Publications and Reprint Services[7]
Contact
- Address:
- Excerpta Medica USA
- 685 US-202
- Bridgewater, NJ 08807
- Telephone +1 908 547 2100
- Fax +1 908 547 2200
- Excerpta Medica EuropeRadarweg 29
- 1043 NX Amsterdam
- Netherlands
- Telephone +31 20 485 3975
- Fax +31 20 485 3188 905 King Street West
- Excerpta Medica Interactive
- 4th Floor
- Toronto, ON
- M6K 3G9 Canada
- Telephone +1 416 955 9449
- Fax +1 416 955 9666
- Website:http://www.excerptamedica.com/
Resources
Notes
- ↑ Excerpta Medica Home page, accessed 16 August 2009
- ↑ Excerpta Medica Publication Policy, accessed 26 August 2009
- ↑ Excerpta Medica Case Studies, retrieved from the Internet Archive dated 10 July 2006 on 26 August 2009.
- ↑ Excerpta Medica Case Studies: With limited clinical support, how did Excerpta Medica establish a client’s product more prominently within its therapeutic marketplace?, accessed 26 August 2009
- ↑ Bob Grant Elsevier published 6 fake journals 07 May 2009, The Scientist, accessed 26 August 2009
- ↑ Excerpta Medica Publication Policy, accessed 26 August 2009
- ↑ Excerpta Medica How to reach us, accessed 26 August 2009
